Ireland News Beep
  • News Beep
  • Ireland
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Ireland News Beep
Ireland News Beep
  • News Beep
  • Ireland
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Glucagon-like Peptide-1

12 posts
HHealth
Patients who stop GLP-1 drugs often restart or try alternatives
Read More

Patients who stop GLP-1 drugs often restart or try alternatives

  • March 17, 2026
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
HHealth
Study: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. Image Credit: Kotcha K / Shutterstock
Read More

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

  • March 9, 2026
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
HHealth
Epigenetic editing enables safer and more effective T cell therapies
Read More

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

  • March 7, 2026
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
HHealth
Review: GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits. Image Credit: Gecko Studio / Shutterstock
Read More

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

  • March 4, 2026
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
TTechnology
Trial: Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial. Image Credit: Alones / Shutterstock
Read More

Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity

  • February 25, 2026
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
HHealth
Improving survival in people with severe psychiatric disorders
Read More

Improving survival in people with severe psychiatric disorders

  • January 26, 2026
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
HHealth
CPAP treatment may reduce death risk in people with both type 2 diabetes and sleep apnea
Read More

Diabetes drugs linked to slower frailty progression in older adults

  • December 4, 2025
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
HHealth
Georgia State scientist receives $25,000 grant to develop mechanisms for treating obesity
Read More

WHO releases first guideline on the use of GLP-1 therapies for treating obesity

  • December 2, 2025
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
HHealth
Stopping GLP-1 drugs before pregnancy leads to more weight gain
Read More

Stopping GLP-1 drugs before pregnancy leads to more weight gain

  • December 1, 2025
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
HHealth
Study: Interest in Facial Volume Restorative Procedures With the Rise in “Ozempic Face”: A Google Trends Analysis. Image Credit: Alones / Shutterstock
Read More

Searches for “Ozempic face” surge as people look for filler-based solutions

  • November 21, 2025
New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
HHealth
Mapping the evolutionary trajectory of meningiomas at single-cell resolution
Read More

Tirzepatide may only temporarily suppress brain activity involved in “food noise”

  • November 18, 2025
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on…
HHealth
Study: Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study. Image Credit: Meteoritka / Shutterstock
Read More

Diabetes remission possible with GLP-1 drugs, Italian study confirms

  • October 30, 2025
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
Ireland News Beep
www.newsbeep.com